1. bookVolume 65 (2016): Issue 4 (December 2016)
Journal Details
License
Format
Journal
eISSN
2544-4646
First Published
04 Mar 1952
Publication timeframe
4 times per year
Languages
English
access type Open Access

Viral Infection of the Heart: Pathogenesis and Diagnosis

Published Online: 28 Feb 2016
Volume & Issue: Volume 65 (2016) - Issue 4 (December 2016)
Page range: 391 - 398
Received: 09 Oct 2015
Accepted: 18 Apr 2016
Journal Details
License
Format
Journal
eISSN
2544-4646
First Published
04 Mar 1952
Publication timeframe
4 times per year
Languages
English
Abstract

Viral infections of the heart cause serious clinical problems, either as infectious myocarditis, which usually is a consequence of acute infection or as idiopathic dilated cardiomyopathy, resulting rather from a chronic infection. This minireview presents an up-to-date view on patho- mechanisms of viral infection of the heart tissues, the role of immune system in controlling infectious process at its various stages and current possibilities of recognizing viral infection of the heart with use of both cardiological and virological methods. Our goal was to present the variety of known viral agents causing heart infection, level of complexity in mutual virus-cell interactions, and consequent clinical scenarios.

Keywords

Abston E.D., M.J. Coronado, A. Bucek, D. Bedja, J. Shin, J.B. Kim, E. Kim, K.L. Gabrielson, D. Georgakopoulos, W. Mitzner and others. 2012. Th2 regulation of viral myocarditis in mice: different roles for TLR3 vs. TRIF in progression to chronic disease. Clin. Dev. Immunol. 2012: 129486.10.1155/2012/129486 Search in Google Scholar

Aretz H.T. 1987. Myocarditis: the Dallas criteria. Hum. Pathol. 18: 619–624.10.1016/S0046-8177(87)80363-5 Search in Google Scholar

Blauwet L.A. and L.T. Cooper. 2010. Myocarditis. Prog. Cardiovasc. Dis. 52(4): 274–88. Search in Google Scholar

Basso C., F. Calabrese, A. Angelini, E. Carturan and G. Thiene. 2013. Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail. Rev. 18(6): 673–681. Search in Google Scholar

Baughman K.L. 2006. Diagnosis of myocarditis: death of Dallas criteria. Circullation. 113: 593–595.10.1161/CIRCULATIONAHA.105.58966316449736 Search in Google Scholar

Bergelson J.M., J.A. Cunningham, G. Droguett, E.A. Kurt-Jones, A. Krithivas, J.S. Hong, M.S. Horwitz, R.L. Crowell and R.W. Fin- berg. 1997. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320–1323.10.1126/science.275.5304.13209036860 Search in Google Scholar

Bock C.T., K. Klingel and R. Kandolf. 2010. Human parvovirus B19-associated myocarditis. N. Engl. J. Med. 362(13): 1248–1249. Search in Google Scholar

Bowles N.E., J. Ni, D.L. Kearney, M. Pauschinger, H.P. Schultheiss, R. McCarthy, J. Hare, J.T. Bricker, K.R. Bowles and J.A. Towbin. 2003. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 42(3): 466–472. Search in Google Scholar

Bültmann B.D., K. Klingel, K. Sotlar, C.T. Bock, H.A. Baba, M. Sauter and R. Kandolf. 2003. Fatal parvovirus B19-asso- ciated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum. Pathol. 34: 92–95.10.1053/hupa.2003.4812605372 Search in Google Scholar

Caforio A.L., F. Calabrese, A. Angelini, F. Tona, A. Vinci, S. Bottaro, A. Ramondo, E. Carturan, S. Iliceto, G. Thiene and others. 2007. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur. Heart J. 28(11): 1326–1333.10.1093/eurheartj/ehm07617493945 Search in Google Scholar

Cooper L.T., K.L. Baughman, A.M. Feldman, A. Frustaci, M. Jessup, U. Kühl, G.N. Levine, J. Narula, R.C. Starling, J. Towbin and others. 2007. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J. Am. Coll. Cardiol. 50(19): 1914–1931.10.1093/eurheartj/ehm45617959624 Search in Google Scholar

Dennert R., H.J. Crijns and S. Heymans. 2008. Acute viral myocarditis. Eur. Heart. J. 29(17): 2073–2082. Search in Google Scholar

Fairweather D., S. Frisancho-Kiss, S.A. Yusung, M.A. Barrett, S.E. Davis, S.J. Gatewood, D.B. Njoku and N.R. Rose. 2004. IFN-g protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines TGF-b1, IL-1b, and IL-4 in the heart. Am. J. Pathol. 165: 1883–1894. Search in Google Scholar

Fairweather D. and N. Rose. 2007. Coxsackievirus-induced myocarditis in mice: A model of autoimmune disease for studying immunotoxicity. Methods. 41: 118–122.10.1016/j.ymeth.2006.07.009176491117161308 Search in Google Scholar

Fuse K., G. Chan, Y. Liu, P. Gudgeon, M. Husain, M. Chen, W.C. Yeh, S. Akira and P.P. Liu. 2005. Myeloid differentiation fac- tor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation. 112: 2276–2285.10.1161/CIRCULATIONAHA.105.53643316216974 Search in Google Scholar

Herzum M., V. Ruppert, B. Kuytz, H. Jomaa, I. Nakamura and B. Maisch. 1994. Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J. Mol. Cell Cardiol. 26(7): 907–913.10.1006/jmcc.1994.11087966359 Search in Google Scholar

Huber S.A., D. Sartini and M. Exley. 2002. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. J. Virol. 76: 10785–10790.10.1128/JVI.76.21.10785-10790.2002 Search in Google Scholar

Kawai C. 1999. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation. 99: 1091–100.10.1161/01.CIR.99.8.1091 Search in Google Scholar

Kawai C. and A. Matsumori. 2013. Dilated cardiomyopathy update: infectious-immune theory revisited. Heart Fail. Rev. 18(6): 703–714.Search in Google Scholar

Kühl U., M. Pauschinger, B. Seeberg, D. Lassner, M. Noutsias, W. Poller and H.P. Schultheiss. 2005. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 112(13): 1965–1970. Search in Google Scholar

Kühl U., M. Pauschinger, P.L. Schwimmbeck, B. Seeberg, C. Lober, M. Noutsias, W. Poller and H.P. Schultheiss. 2003. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 107: 2793–2798.10.1161/01.CIR.0000072766.67150.51 Search in Google Scholar

Kühl U. and H.P. Schultheiss. 2009. Viral myocarditis: diagnosis, aetiology and management. Drugs. 69(10): 1287–1302.10.2165/00003495-200969100-00001 Search in Google Scholar

Lafyatis R. and A. Farina. 2012. New insights into the mechanisms of innate immune receptor signalling in fibrosis. The Open Rheum. J. 6(Suppl 1: M2): 72–79.10.2174/1874312901206010072 Search in Google Scholar

Leslie K., R. Blay, C. Haisch, A. Lodge, A. Weller and S. Huber. 1989. Clinical and experimental aspects of viral myocarditis. Clin. Microbiol. Rev. 2(2): 191–203. Search in Google Scholar

Li K., W. Xu, Q. Guo, Z. Jiang, P. Wang, Y. Yue and S. Xiong. 2009. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility toviral myocarditis. Circ. Res. 105: 353–364.10.1161/CIRCRESAHA.109.195230 Search in Google Scholar

Luo H., J. Zhang, C. Cheung, A. Suarez, B.M. McManus and D. Yang. 2003. Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes. Am. J. Pathol. 163: 381–385.10.1016/S0002-9440(10)63667-XSearch in Google Scholar

Mahfoud F, B. Gärtner, M. Kindermann, C. Ukena, K. Gadomski, K. Klingel, R. Kandolf, M. Böhm and I. Kindermann. 2011. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J. 32: 897–903.10.1093/eurheartj/ehq49321217143 Search in Google Scholar

Mahrholdt H., C. Goedecke, A. Wagner, G. Meinhardt, A. Atha- nasiadis, H. Vogelsberg, P. Fritz, K. Klingel, R. Kandolf and U. Sechtem. 2004. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 109: 1250–1258.10.1161/01.CIR.0000118493.13323.8114993139 Search in Google Scholar

Maisch B. and S. Pankuweit. 2013. Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail. Rev. 18(6): 761–795.10.1007/s10741-012-9362-723225133 Search in Google Scholar

Maisch B., B.D. Bültmann, S. Factor, H.J. Gröne, G. Hufnagel, K. Kawamura, U. Kühl, E.J. Olsen, S. Pankuweit and R. Virmani. 1999. World Heart Federation con-sensus conferences’ definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat. 4: 3–4.10.1007/s000590050007 Search in Google Scholar

Martin A.B., S. Webber, F.J. Fricker, R. Jaffe, G. Demmler, D. Kearney, Y.H. Zhang, J. Bodurtha, B. Gelb and J. Ni. 1994. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation. 90: 330–339.10.1161/01.CIR.90.1.330 Search in Google Scholar

Martino T.A., P. Liu and M.J. Sole. 1994. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ. Res. 74: 182–188.10.1161/01.RES.74.2.182 Search in Google Scholar

Mason J.W., J.B. O’Cornell, A. Herscowitz, N.R. Rose, B.M. McManus, M.E. Bilingham and T.E. Moon. 1995. A Clinical trial of immunosupressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N. Engl. J. Med. 333: 269–275.10.1056/NEJM199508033330501 Search in Google Scholar

Negishi H., T. Osawa, K. Ogami, X. Ouyang, S. Sakaguchi, R. Koshiba, H. Yanai, Y. Seko, H. Shitara, K. Bishop and others. 2008. A critical link between Toll-like receptor 3 and type I interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. USA 105(51): 20446–20451.10.1073/pnas.0810372105 Search in Google Scholar

Nie X., G. Zhang, D. Xu, X. Sun, Z. Li, X. Li, X. Zhang, F. He and Y. Li. 2010. The VP1-unique region of parvovirus B19 induces myocardial injury in mice. Scand. J. Infect. Dis. 42: 121–128.10.3109/00365540903321580 Search in Google Scholar

O’Malley A., C. Barry-Kinsella, C. Hughes, P. Kelehan, D. Devaney, E. Mooney and J. Gillan. 2003. Parvovirus infects cardiac myocytes in hydrops fetalis. Pediatr. Dev. Pathol. 6: 414–420.10.1007/s10024-001-0269-x Search in Google Scholar

Pankuweit S., R. Moll, U. Baandrup, I. Portig, G. Hufnagel and B. Maisch. 2003. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum. Pathol. 34: 497–503.10.1016/S0046-8177(03)00078-9 Search in Google Scholar

Pankuweit S. and K. Klingel. 2013. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail. Rev. 18(6): 683–702. Search in Google Scholar

Sagar S., P.P. Liu and L.T. Jr. Cooper. 2012. Myocarditis. Lancet 379(9817): 738–74710.1016/S0140-6736(11)60648-X Search in Google Scholar

Shi Y., C. Chen, U. Lisewski, U. Wrackmeyer, M. Radke, D. Wester- mann, M. Sauter, C. Tschöpe, W. Poller, K. Klingel and others. 2009. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J. Am. Coll. Cardiol. 53: 1219–1226.10.1016/j.jacc.2008.10.06419341864 Search in Google Scholar

Schmidt-Lucke C., F. Spillmann, T. Bock, U. Kühl, S. Van Lin- thout, H.P. Schultheiss and C. Tschöpe. 2010. Interferon Beta Modulates Endothelial Damage in Patients with Cardiac Persistence of Human Parvovirus B19 Infection. J. Infect. Dis. 201–20610.1086/65070020158391 Search in Google Scholar

Stewart P.L. and G.L. Nemerow. 2007. Cell integrins: commonly used receptors for diverse viral pathogens. Trends in Microbiology 15(11): 500–507.10.1016/j.tim.2007.10.00117988871 Search in Google Scholar

Tanaka T., T. Kanda, B.M. McManus, H. Kanai, H. Akiyama, K. Sekiguchi, T. Yokoyama and M. Kurabayashi. 2001. Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-α. J. Mol. Cell. Cardiol. 33: 1627–1635.10.1006/jmcc.2001.142811549342 Search in Google Scholar

Tzang B.S., T.M. Lin, C.C. Tsai, J.D. Hsu, L.C. Yang and T.C. Hsu. 2011. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. Mol. Immunol. 48: 1518–1524.10.1016/j.molimm.2011.04.01321555155 Search in Google Scholar

Woodruff J.F. 1980. Viral myocarditis. A review. Am. J. Pathol. 101(2): 425–484. Search in Google Scholar

Yajima T. 2011. Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection. Future Microbiol. 6: 551–566.10.2217/fmb.11.40313113521585262 Search in Google Scholar

Yasukawa H., T. Yajima, H. Duplain, M. Iwatate, M. Kido, M. Hoshijima, M.D. Weitzman, T. Nakamura, S. Woodard, D. Xiong and others. 2003. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J. Clin. Invest. 111(4): 469–478. Search in Google Scholar

Yuan J., A.L. Cao, M. Yu, Q.W. Lin, X. Yu, J.H. Zhang, M. Wang, H.P. Guo and Y.H. Liao. 2010. Th17 cells facilitate the humoral immune response in patients with acute viral myocarditis. J. Clin. Immunol. 30: 226–234.10.1007/s10875-009-9355-z20012175 Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo